Composite containing collagen and elastin as a dermal expander and tissue filler
An injectable composition having dermal filling and tissue expanding activity comprises (1) a quantity of elastin sufficient to bring about dermal filling and tissue expansion when injected into a subject in need of dermal filling and tissue expansion, and (2) a pharmaceutically acceptable carrier. The composition can further comprise collagen, in other alternatives, the composition can further comprise hyaluronic acid, and one or more of the elastin, the collagen, and the hyaluronic acid, if present can be cross-linked, either intramolecularly or intermolecularly. The elastin, however, is the primary filler, even if collagen or hyaluronic acid are included in the composition.
1. An injectable composition having dermal filling and tissue expanding activity comprising:
(a) a quantity of elastin sufficient to bring about dermal filling and tissue expansion when injected into a subject in need of dermal filling and tissue expansion; and
(b) a pharmaceutically acceptable carrier;
wherein the composition possesses space filling activity owing to its elastin content; and
wherein the composition further comprises collagen;
wherein the collagen is cross-linked intramolecularly in vitro with a cross-linking agent.
2. The composition of claim 1 wherein the collagen is used in soluble form, fibrillar form, a form of an insoluble slurry, or hydrogel form.
3. An injectable composition having dermal filling and tissue expanding activity comprising:
(a) a quantity of elastin sufficient to bring about dermal filling and tissue expansion when injected into a subject in need of dermal filling and tissue expansion; and
(b) a pharmaceutically acceptable carrier;
wherein the composition possesses space filling activity owing to its elastin content;
wherein the composition further comprises collagen and a glycosaminoglycan, and wherein one or more of the elastin, the collagen, and the glycosaminoglycan are cross-linked, either intramolecularly or intermolecularly in vitro with a cross-linking agent, wherein the glycosaminoglycan is selected from the group consisting of hyaluronic acid, chondroitin sulfate, pentosan polysulfate, dermatan sulfates, heparin, heparan sulfates, and keratan sulfates.
4. The composition of claim 3 wherein the collagen is used in soluble form, fibrillar form, a form of an insoluble slurry, or hydrogel form.